Post-weaning selenium and folate supplementation affects gene and protein expression and global DNA methylation in mice fed high-fat diets by unknown
Bermingham et al. BMC Medical Genomics 2013, 6:7
http://www.biomedcentral.com/1755-8794/6/7RESEARCH ARTICLE Open AccessPost-weaning selenium and folate
supplementation affects gene and protein
expression and global DNA methylation in mice
fed high-fat diets
Emma N Bermingham1, Shalome A Bassett1, Wayne Young1, Nicole C Roy1,2, Warren C McNabb2,3,
Janine M Cooney4, Di T Brewster5, William A Laing5 and Matthew PG Barnett1*Abstract
Background: Consumption of high-fat diets has negative impacts on health and well-being, some of which may
be epigenetically regulated. Selenium and folate are two compounds which influence epigenetic mechanisms. We
investigated the hypothesis that post-weaning supplementation with adequate levels of selenium and folate in
offspring of female mice fed a high-fat, low selenium and folate diet during gestation and lactation will lead to
epigenetic changes of potential importance for long-term health.
Methods: Female offspring of mothers fed the experimental diet were either maintained on this diet (HF-low-low),
or weaned onto a high-fat diet with sufficient levels of selenium and folate (HF-low-suf), for 8 weeks. Gene and
protein expression, DNA methylation, and histone modifications were measured in colon and liver of female
offspring.
Results: Adequate levels of selenium and folate post-weaning affected gene expression in colon and liver of
offspring, including decreasing Slc2a4 gene expression. Protein expression was only altered in the liver. There was
no effect of adequate levels of selenium and folate on global histone modifications in the liver. Global liver DNA
methylation was decreased in mice switched to adequate levels of selenium and folate, but there was no effect on
methylation of specific CpG sites within the Slc2a4 gene in liver.
Conclusions: Post-weaning supplementation with adequate levels of selenium and folate in female offspring of
mice fed high-fat diets inadequate in selenium and folate during gestation and lactation can alter global DNA
methylation in liver. This may be one factor through which the negative effects of a poor diet during early life can
be ameliorated. Further research is required to establish what role epigenetic changes play in mediating observed
changes in gene and protein expression, and the relevance of these changes to health.
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The epigenome comprises interconnected, interdepend-
ent heritable processes (including DNA methylation, his-
tone modifications, and non-coding RNAs) that regulate
gene expression in response to environmental influences.
Epigenetic regulation may be as important as DNA tran-
scription and translation for allowing plasticity of the
phenotype in a fixed genotype [1]. There is mounting
evidence that epigenetics has a major role in multiple
physiological processes including development, imprint-
ing, and regulation of gene transcription [2]. Activation
or deactivation of genes in response to various deleteri-
ous environmental stimuli may be important in the de-
velopment of common complex diseases [3,4]. Specific
nutrients can modulate epigenetic events [5,6], indicat-
ing that diet may be a key environmental factor which
can influence epigenetic patterns [7,8], with consequent
effects on gene expression. It is therefore important to
investigate the potential of food components to induce
phenotypic changes via epigenetic modulation of gene
expression [9].
A genetic predisposition to good health may be
established at conception by the combination of genetic
material from both parents [10]. However, the effects of
environmental impacts throughout life, particularly dur-
ing critical times such as gestation, can influence the ex-
pression of the genetic potential of the individual,
resulting in altered phenotype [10]. Macronutrient-rich
diets high in carbohydrate, protein and fat may have in-
adequate levels of micronutrients, especially if the food
components are heavily processed [11]. Poor micronu-
trient intake, which is often associated with high con-
sumption of such foods, has been linked to late onset
diseases such as cancer [12]. Selenium is an essential
micronutrient which is deficient in diets in several coun-
tries, including New Zealand [13], and this deficiency
can result in symptoms associated with oxidative stress
[14]. Folate, a water-soluble B vitamin with roles in
DNA synthesis and repair, is also nutritionally inad-
equate in diets in many countries [15]. Both selenium
and folate can influence gene expression, possibly via
epigenetic mechanisms [16]. Folate is thought to affect
epigenetic regulation via one-carbon metabolism, how-
ever the epigenetic regulation by selenium is less well
understood [17]. Selenium is thought to modulate folate
deficiency, suggesting that the interaction between folate
and selenium is important [16].
Epigenetic activation and repression is important in
normal cellular development and maintenance [18].
While particularly important during foetal development,
these processes have also been implicated in postnatal
development, affecting for example both structure and
function of the mammalian gastrointestinal tract [19].
Histone modification and DNA methylation are majorepigenetic mechanisms [20]. In the case of methylation,
the general dogma suggests that the addition of methyl
groups by DNA methyltransferase represses gene ex-
pression, while methyl removal allows activation [21].
Dysregulation of these processes may lead to negative
impacts on health [22]. Histone modifications include
both acetylation and deacetylation (amongst other modi-
fications); DNA methylation and histone modifications
can act together to provide stable and heritable gene si-
lencing in eukaryotic genomes [23].
We hypothesised that post-weaning supplementation
with adequate levels of selenium and folate after expos-
ure (via maternal diet during gestation and lactation) to
high fat and low selenium and folate will lead to epigen-
etic changes in the offspring which are of importance for
long-term health, with a high-fat diet being a risk factor
for obesity. Of interest are the long-term effects of
intergenerational epigenetic regulation, which are more
likely to be carried through the maternal line [24]. To
test this hypothesis, female mice were fed a high-fat diet
containing low levels of selenium and folate during ges-
tation and lactation. At four weeks of age, female
offspring were either weaned onto the same diet (HF-
low-low), or onto a high-fat diet containing adequate
selenium and folate (HF-low-suf ). At 12 weeks of age,
gene and protein expression profiles, and DNA methyla-
tion (global and gene-specific) were measured in colon
and liver, and selenium content and histone H3 methyla-
tion and acetylation measured in the liver. These ana-
lyses showed changes in gene and protein expression in
metabolic and oxidative pathways, and altered global
DNA methylation, due to post-weaning supplementation
with selenium and folate.
Results
Food intake and body weight
There was no effect of adequate levels of selenium and fol-
ate post-weaning on food intake (c. 2.7 g diet/day;
P = 0.91) or bodyweight (c. 18.5 g; P = 0.66) of offspring.
Liver selenium content
There was a small but significant effect of diet on liver
selenium, with levels in mice in the HF-low-suf group
being slightly higher than those in mice in the HF-low
-low group (1.03 ± 0.12 vs. 0.85 ± 0.15 mg/kg, P < 0.05).
Gene and protein expression profiles
Post-weaning supplementation with adequate levels of
selenium and folate altered the expression (P < 0.01, |fold
change| >1.5) of 23 genes in the colon (Additional file 1:
Table S1). The majority of these genes were significantly
over-represented in Gene Ontology (GO) biological pro-
cesses related to cellular and DNA metabolic processes
(Table 1). The biological process “Lipid homeostasis”
Table 1 Significantly over-represented gene ontology biological processes associated with differentially expressed
genes in the colon of mice supplemented with adequate levels of selenium and folate post-weaning










Organelle organization GO:0006996 Top2a NM_011623 Mus musculus topoisomerase (DNA) II alpha −1.7 0.006
Stx6 NM_021433 Mus musculus syntaxin 6 −1.6 0.003
Col4a3bp NM_023420
Mus musculus procollagen, type IV, alpha 3 (Goodpasture
antigen) binding protein
−1.5 0.004
Pom121 NM_148932 Mus musculus nuclear pore membrane protein 121 −1.7 0.004
Shprh AK037266 Mus musculus 16 days neonate thymus −1.6 0.003
Lipid homeostasis GO:0055088 Col4a3bp NM_023420
Mus musculus procollagen, type IV, alpha 3 (Goodpasture
antigen) binding protein
−1.5 0.004
Plscr3 NM_023564 Mus musculus phospholipid scramblase 3 −1.6 0.007
Cellular component
organization
GO:0016043 Nov NM_010930 Mus musculus nephroblastoma overexpressed gene −1.7 0.005
Top2a NM_011623 Mus musculus topoisomerase (DNA) II alpha −1.7 0.006
Stx6 NM_021433 Mus musculus syntaxin 6 −1.6 0.003
Col4a3bp NM_023420
Mus musculus procollagen, type IV, alpha 3 (Goodpasture
antigen) binding protein
−1.5 0.004
Pom121 NM_148932 Mus musculus nuclear pore membrane protein 121 −1.7 0.004
Shprh AK037266 Mus musculus 16 days neonate thymus −1.6 0.003
Nuclear pore
organization
GO:0006999 Pom121 NM_148932 Mus musculus nuclear pore membrane protein 121 −1.7 0.004
Cellular process GO:0009987 Heph NM_181273 Mus musculus hephaestin, transcript variant 2 −1.5 0.001
Mef2a NM_001033713 Mus musculus myocyte enhancer factor 2A −1.6 0.001
Nov NM_010930 Mus musculus nephroblastoma overexpressed gene −1.7 0.005
Rora AK087905 Mus musculus 2 days pregnant adult female ovary −1.8 0.001
Top2a NM_011623 Mus musculus topoisomerase (DNA) II alpha −1.7 0.006
Mtmr1 NM_016985 Mus musculus myotubularin related protein 1 −1.6 0.008
Stx6 NM_021433 Mus musculus syntaxin 6 −1.6 0.003
Col4a3bp NM_023420
Mus musculus procollagen, type IV, alpha 3 (Goodpasture
antigen) binding protein
−1.5 0.004
Pom121 NM_148932 Mus musculus nuclear pore membrane protein 121 −1.7 0.004
Shprh AK037266 Mus musculus 16 days neonate thymus −1.6 0.003
Podxl2 NM_176973 Mus musculus podocalyxin-like 2 −1.6 0.005
DNA packaging GO:0006323 Top2a NM_011623 Mus musculus topoisomerase (DNA) II alpha −1.7 0.006
Shprh AK037266 Mus musculus 16 days neonate thymus −1.6 0.003
DNA conformation
change
GO:0071103 Top2a NM_011623 Mus musculus topoisomerase (DNA) II alpha −1.7 0.006
Shprh AK037266 Mus musculus 16 days neonate thymus −1.6 0.003
DNA metabolic process GO:0006259 Top2a NM_011623 Mus musculus topoisomerase (DNA) II alpha −1.7 0.006
Shprh AK037266 Mus musculus 16 days neonate thymus −1.6 0.003
A positive fold change indicates that supplementation increased the expression of the gene.
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the differentially expressed genes in the colon. The mRNA
abundance of the majority of genes in the colon was
decreased (Table 1).
In the liver, post-weaning supplementation with ad-
equate levels of selenium and folate led to differentialexpression (P < 0.01, FC > 1.5) of 36 genes (Additional file
2: Table S2), within which the GO biological processes,
“Cellular process”, “Multicellular organismal process”,
“Developmental process”, and “Multicellular organismal
development” were significantly over-represented (P < 0.05)
(Table 2). Whilst the mRNA abundance of the majority of
Table 2 Significantly over-represented gene ontology biological processes associated with differentially expressed
genes in the liver of mice supplemented with adequate levels of selenium and folate post-weaning
(n = 6 per treatment)





Multicellular organismal process GO:0032501 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Isl1 NM_021459








Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
Ndrg4 NM_145602








Mus musculus clone OR27-3 putative olfactory
receptor mRNA
−1.53 0.001
Olfr357 NM_146623 Mus musculus olfactory receptor 357 −1.52 0.008
Olfr646 NM_147056 Mus musculus olfactory receptor 646 −1.67 0.010
Developmental process GO:0032502 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Isl1 NM_021459








Mus musculus solute carrier family 2 (facilitated
glucose transporter), member 4
−2.39 0.001
Ift172 NM_026298
Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 −1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
Ndrg4 NM_145602




Mus musculus Fras1 related extracellular matrix
protein 2
−1.52 0.007












Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008 −1.68 0.008
Bermingham et al. BMC Medical Genomics 2013, 6:7 Page 4 of 18
http://www.biomedcentral.com/1755-8794/6/7
Table 2 Significantly over-represented gene ontology biological processes associated with differentially expressed
genes in the liver of mice supplemented with adequate levels of selenium and folate post-weaning
(n = 6 per treatment) (Continued)
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
Ndrg4 NM_145602




Mus musculus Fras1 related extracellular matrix
protein 2
−1.52 0.007
Cellular process GO:0009987 Fpr-rs2 NM_008039
Mus musculus formyl peptide receptor, related
sequence 2
1.51 0.005
Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Isl1 NM_021459








Mus musculus solute carrier family 2 (facilitated
glucose transporter), member 4
−2.39 0.001
Ift172 NM_026298
Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Pcdhb10 NM_053135 Mus musculus protocadherin beta 10 −1.52 0.005
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
C79407 NM_172578 Mus musculus expressed sequence C79407 −1.66 0.005
Spon1 AK084717 Mus musculus 13 days embryo heart cDNA −1.66 0.004
Tnrc6a AK147327 Mus musculus cDNA −1.71 0.003
Frem2 NM_172862




Mus musculus clone OR27-3 putative olfactory
receptor
−1.53 0.001
Olfr357 NM_146623 Mus musculus olfactory receptor 357 −1.52 0.008
Olfr646 NM_147056 Mus musculus olfactory receptor 646 −1.67 0.010
System development GO:0048731 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Isl1 NM_021459








Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
Frem2 NM_172862
Mus musculus Fras1 related extracellular matrix
protein 2
−1.52 0.007
Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Organ development GO:0048513 Isl1 NM_021459
Mus musculus ISL1 transcription factor, LIM/
homeodomain
−1.59 0.007
Mbp NM_010777 −1.62 0.004
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Table 2 Significantly over-represented gene ontology biological processes associated with differentially expressed
genes in the liver of mice supplemented with adequate levels of selenium and folate post-weaning
(n = 6 per treatment) (Continued)
Mus musculus myelin basic protein, transcript
variant 7
Ift172 NM_026298
Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
Frem2 NM_172862
Mus musculus Fras1 related extracellular matrix
protein 2
−1.52 0.007
Cellular developmental process GO:0048869 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Isl1 NM_021459








Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
Frem2 NM_172862





GO:0048856 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Isl1 NM_021459








Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Mcoln3 AK033008
Mus musculus 12 days embryo male wolffian duct
includes surrounding region cDNA
−1.68 0.008
Frem2 NM_172862






GO:0010605 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
Ift172 NM_026298
Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Dmbx1 NM_130865
Mus musculus diencephalon/mesencephalon
homeobox 1, transcript variant 1
−1.50 0.010
Tnrc6a AK147327 Mus musculus cDNA −1.71 0.003
Cell surface receptor linked
signaling pathway
GO:0007166 Il2 NM_008366 Mus musculus interleukin 2 −1.50 0.010
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Table 2 Significantly over-represented gene ontology biological processes associated with differentially expressed
genes in the liver of mice supplemented with adequate levels of selenium and folate post-weaning
(n = 6 per treatment) (Continued)
Ift172 NM_026298
Mus musculus intraflagellar transport 172
homolog (Chlamydomonas)
−1.52 0.002
Plce1 AK035546 Mus musculus adult male urinary bladder cDNA 1.53 0.010
Errfi1 NM_133753 Mus musculus ERBB receptor feedback inhibitor 1 1.73 0.000
Olfr1355 AF042360
Mus musculus clone OR27-3 putative olfactory
receptor
−1.53 0.001
Olfr357 NM_146623 Mus musculus olfactory receptor 357 −1.52 0.008
Olfr646 NM_147056 Mus musculus olfactory receptor 646 −1.67 0.010
A positive fold change indicates that supplementation increased the expression of the gene.
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dance of Dmbx1, Errfi1, Plce1 and Fpr-rs2 transcripts was
increased in the liver (Table 2) in offspring supplemented
with adequate levels of selenium and folate.
Pooled differential proteomic analysis (HF-low-suf vs.
HF-low-low) showed no effect of post-weaning supple-
mentation with adequate levels of selenium and folate
on protein expression in the colon (data not shown).
In the liver, 22 proteins were differentially expressed
(P < 0.05; Figure 1) and are shown in the gel image
depicted in Additional file 3: Figure S1, and listed in
Figure 1. These included proteins with a role in the oxida-
tive stress response, metabolic proteins (in particular those
in the urea cycle and amino acid metabolism), and cyto-
skeletal proteins such as actin and tropomysin (Figure 1).
A network of interactions between genes and proteins,
and the changes in expression associated with feeding of the
HF-low-suf diet, can be seen in Figure 2. As shown in
Figure 3, gene and protein expression fold changes in the
liver were not highly correlated (Pearson Coefficient = 0.33).
Global DNA methylation and histone modifications
There were no significant differences in the global levels
of histone H3 acetylation (H3K9ac; P = 0.808) or methy-
lation (H3K9me2; p = 0.788) detected in liver, while there
was insufficient material available to accurately measure
either of these changes in colon (Table 3).
Gene-specific methylation of Slc2a4
The expression of the Slc2a4 gene in liver was signifi-
cantly down-regulated in supplemented mice; micro-
array data showed consistent decreased Slc2a4 mRNA
abundance due to adequate selenium and folate supple-
mentation, with 8 separate probes for this gene on the
array showing a >2 |fold-change| (range −2.10 to −2.39).
In addition, methylation of sites in the promoter region
of Slc2a4 gene has been associated with transcriptional
control of this gene [25,26]. This gene was therefore
chosen to investigate gene-specific methylation. Data
were generated by Sequenom analysis for 6 individualCpG sites (1, 4, 6, 9, 16 and 17) and two CpG clusters
(12-13-14-15, and 22–23) within the first amplicon
(pp_27), and 6 individual CpG sites (1, 2, 3, 5, 6 and 9)
within the second amplicon (pp_46). There were no sig-
nificant differences with respect to the percentage
methylation of any of these CpG sites due to selenium
and folate supplementation post-weaning in mice fed
high-fat diets (Figure 4), and there was also no effect on
the overall pattern of methylation.
Discussion
The study reported here shows that post-weaning sup-
plementation with adequate levels of selenium and folate
(following maternal consumption of a high-fat diet low
in selenium and folate during gestation and lactation) al-
tered metabolism-related pathways in both liver and
colon. In colon, differential expression of genes was ob-
served in DNA metabolic processes, with no changes
observed in protein expression. In the liver, differential
expression of both genes and proteins was observed (al-
though not necessarily concomitant), and a reduction of
total DNA methylation was also seen.
Gene and protein expression
Analysis of the effect of post-weaning supplementation
of adequate levels of selenium and folate on liver protein
expression identified differential expression of proteins
involved in oxidative stress response, metabolism, and
cytoskeletal assembly. The changes in oxidative stress re-
sponse are likely to be due to the antioxidant role of sel-
enium being enhanced due to supplementation. Changes
in expression levels of genes and their corresponding
proteins were not highly correlated. This is not surpris-
ing, as the use of direct gene/protein correlation mea-
sures is unlikely to reflect the actual correspondence
between the expression of a gene and its protein, which
is complicated due to post-transcriptional and transla-
tional regulation [27]. Nevertheless, in this study both
protein and/or gene expression patterns were altered in








change protein identified 
Oxidative stress/Nrf2 mediated oxidative stress 
response/ Response to hypoxia 
3 gi|33563240 Acta1* 2.8 actin, alpha 1, skeletal muscle 
3 gi|6752954 Actg1* 2.8 actin, gamma, cytoplasmic 1  
1 gi|31982300 Hbb-b1 36.9 hemoglobin, beta adult major chain  
1 gi|255708425 Mb 36.9 myoglobin  
2 gi|6754976 Prdx1 1.8 peroxiredoxin 1  
4 gi|6754976 Prdx1 1.9 peroxiredoxin 1  
5 gi|10129957 Prdx5 3.9 peroxiredoxin 5  
Metabolism 
7 gi|29126205 Acaa2 1.5 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) 
11 gi|16741754 Asl 1.5 argininosuccinate lyase  
10 gi|6996911 Ass1 15.3 argininosuccinate synthetase 1  
7 gi|6996911 Ass1 1.5 argininosuccinate synthetase 1  
14 gi|124248512 Cps1 1.5 carbamoyl-phosphate synthetase 1 precursor  
13 gi|199559885 Eno1 1.6 enolase 1, alpha non-neuron-like  
15 gi|160298209 Got1 1.6 glutamate oxaloacetate transaminase 1, soluble 
6 gi|116283875 Hgd 2.0 Hgd protein  
6 gi|31560689 Hmgcs2 2.0 hydroxymethylglutaryl-CoA synthase 2 precursor  
11 gi|31560689 Hmgcs2 1.5 hydroxymethylglutaryl-CoA synthase 2 precursor  
9 gi|172072677 Uroc1 1.7 urocanase domain containing 1 
Cytoskeletal 
3 gi|33563240 Acta1* 2.8 actin, alpha 1, skeletal muscle 
3 gi|6752954 Actg1* 2.8 actin, gamma, cytoplasmic 1  
8 gi|62027399 Tpm3 1.6 Tpm3 protein  
8 gi|47894398 Tpm4 1.6 tropomyosin 4  
Miscellaneous 
12 gi|56605979 Btf3 1.5 basic transcription factor 3  
16 gi|254588014 Etfdh 1.2 electron-transferring-flavoprotein dehydrogenase precursor 
Figure 1 Changes in protein expression in the liver of mice supplemented with adequate levels of selenium and folate post-weaning.
This analysis is of duplicate technical replicates representing protein pooled from the 6 mice per treatment group used for microarray analysis. A
positive fold change indicates that supplementation increased the expression of the protein. Note that 16 differentially expressed protein “spot-
features” were identified, representing 22 unique proteins (spot features 1, 3, 6, 7, 8, and 11 each contain 2 proteins). * Indicates that a protein
appears in multiple functional groups.
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and DNA metabolic process pathways, multicellular or-
ganismal process, developmental process, and multicel-
lular organismal development) indicating a potentially
important developmental role for post-weaning supple-
mentation of selenium and folate.
One gene which showed common differential expres-
sion of both transcript and protein was myoglobin,
which had higher expression levels in offspring which
had received the adequate diets. This is consistent with
studies showing that administration of folic acid can en-
hance porphyrin production [28]. The haeme porphyrin
ring is an essential component of both myoglobin and
haemoglobin, and because folate functions as a carbon
carrier in the formation of haeme [29], folate supple-
mentation may result in increased availability of haeme.This may be one mechanism explaining the observed
large increase in myoglobin gene and protein expression,
and in haemoglobin protein expression, in the current
study.
There were no genes that showed altered expression
in both liver and colon. It is known that selenium sup-
plementation effects selenoprotein activity differently in
different tissues [30]. Furthermore, while liver is the
main tissue of folate storage and metabolism [31], sup-
plementation with methyl donors including folic acid
has been shown to affect gene expression and DNA
methylation in colon tissue in a mouse model of colitis
[32], suggesting that colon may be an important target
tissue for folate supplementation. It has also been shown
that the effects of folate supplementation can differ de-
pending on age and tissue [33]. It is therefore not
Figure 2 The effects of adequate selenium and folate post-weaning on differentially expressed genes and proteins in the liver of
female mice exposed to high-fat diets with low selenium and folate during gestation and lactation. A network of genes (Δ) and proteins
(Ο) was generated using Ingenuity Pathways Analysis software. All genes and proteins differentially expressed in the liver in response to altered
selenium and folate levels were included, and the IPA knowledge base developed links between these based on direct interactions previously
reported in the literature. Genes and gene products with higher expression in the deficient animals are shown in red, those with lower
expression in green. This approach was used to identify whether any genes or proteins showed direct interactions with a large number of other
genes or proteins, and may therefore be of particular importance in mediating the effects of altered dietary selenium and folate.
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of gene and protein expression in these tissues in the
current study, particularly given the relatively small
number of genes and proteins that were differentially
expressed in response to different levels of selenium and
folate.DNA methylation
We observed a small (approximately 10%) but significant
decrease of global DNA methylation in the liver of off-
spring fed selenium and folate supplemented. Other
studies have shown varying effects of selenium and folate
supplementation on global DNA methylation. For
Figure 3 Comparison of gene and protein data using unsupervised hierarchical clustering in the liver. Comparison of gene (“microarray
FC”) and corresponding protein (protein FC) expression levels in liver tissue of mice receiving adequate levels of folate and selenium post-
weaning with expression levels in liver of mice with low dietary selenium and folate. Yellow (fold change >1) indicates greater expression in HF-
Low-Suf mice, blue (fold change < 1) indicates greater expression in HF-Low-Low mice. Proteins and genes were non-hierarchically clustered
according to similarity in fold change. Multiple instances of genes/protein names indicate multiple microarray probes/protein spots. Data for all
gene expression changes are shown in Additional file 1: Table S1 and Additional file 2: Table S2, and for protein changes in Figure 1.
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http://www.biomedcentral.com/1755-8794/6/7example, selenium deficiency decreased global DNA
methylation in the colon, with no effect in liver, in
Fischer-344 rats fed a deficient diet from weaning; in the
same study, folate had no effect on global DNA methyla-
tion [34]. In contrast, and in agreement with our data,
adequate (0.15 mg/kg diet) and supra-nutritional (4 mg/
kg diet) selenium supplementation decreased total DNA
methylation levels in the liver of rats maintained onTable 3 The effects of adequate levels of selenium and
folate post-weaning life on histone H3 modifications
(acetylation or methylation of lys9 residue, mean peak
intensity) in the liver of mice fed high-fat diets
Tissue HF-low-low HF-low-suf
n = 6 n = 6 SE P-value
H3K9ac 100.0 109.1 0.15 0.808
H3K9me2 100.0 109.1 0.14 0.788
Note that colon was not studied as insufficient protein was obtained from
these tissues to perform the analysis.standard diets (AIN-93 G), compared to deficient diets
[35]. This study involved feeding a standard diet,
whereas our study had a high-fat diet, thus the same ef-
fect of supplementation on total DNA methylation has
been observed within the context of two different diets.
A reduction in overall levels of DNA methylation in
the liver may indicate increased transcriptional activity,
because methylation is usually inversely correlated with
the transcriptional status of genes [36]. Although an
overall reduction in liver DNA methylation was ob-
served in mice supplemented with selenium and folate
in the current study, genes differentially expressed in the
liver largely showed reduced expression in response to
supplementation. It has recently been observed that the
epigenetic effects of folate on DNA methylation are
highly complex, with factors such as gene and site
specificity, cell type, target organ, degree and duration of
folate manipulations, and interactions with other methyl





















Figure 4 Methylation of CpG sites at, and upstream of, the transcription start site of the Slc2a4 gene. The promoter region and
transcription start site of the Slc2a4 gene were targeted to establish if differential DNA methylation was occurring at specific CpG sites within
these regions. The upper panel represents the position of CpG islands, target amplicons, and CpG sites within the target region, while the graph
represents mean ± SEM for the percentage methylation at each site, as measured using Sequenom EpiTYPER. No significant differences were
observed as a result of selenium and folate supplementation for any of the CpG sites measured.
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http://www.biomedcentral.com/1755-8794/6/7influencing the effects [37]. It is therefore perhaps not
surprising that there is not a simple link between in-
creased dietary folate and the degree of methylation, nor
between methylation and gene expression. Results from
our study may also be complicated by potential interac-
tions between folate and selenium. Furthermore, a re-
cently reported human population study found no
positive associations between intake of methyl donor nu-
trients during pregnancy and overall DNA methylation
in offspring [38].
Folate depletion has been associated with gene-specific
changes in DNA methylation, for example of the p53
[39] and Slc394a [40] genes. Information on concurrent
selenium and folate supplementation is less widely avail-
able. In the current study, we observed decreased ex-
pression of the Slc2a4 gene (which encodes the glucose
transporter GLUT4) in offspring of the adequate selen-
ium/folate group. It has been observed that combining
selenium with insulin was able to restore, among other
things, disturbances in GLUT4 levels in cardiac muscle
in diabetic rats. Furthermore, methylation of sites in the
promoter region of Slc2a4 gene has been associated with
transcriptional control of this gene [25,26]. In this study,
however, we found no association between changes in
Slc2a4 expression and altered methylation in the pro-
moter region. The site of methylation may be an import-
ant factor in the regulation of gene expression, with
methylation of CpG sites in the promoter region closest
to the transcription start site having more influence on
gene expression than those further from this region due
to the effects of methylation on transcription factorbinding [41]. Several studies have also shown that CpG
methylation within introns is associated with changes in
gene expression [42-44]. It is therefore possible that
CpG sites within the Slc2a4 gene that were not analysed
in the current study were differentially methylated, and
thereby influenced its levels of expression. It is also
plausible that the overall reduction in methylation ob-
served in this study may have occurred in non-coding
regions of the genome, or that a ‘redistribution’ of me-
thyl marks may have occurred in response to altered
dietary folate/selenium. A more comprehensive analysis
of methylation, both across the Slc2a4 gene and at a
genome-wide level, would be required to further clarify
these points.
It is also important to note that CpG methylation is
only one possible factor by which gene expression may
be regulated [41]. For example, modifications of chroma-
tin structure, including acetylated histone H3, acetylated
histone H4 and di-methylated histone H3 at lysine 4,
within the promoter region have been shown to regulate
expression of the Slc2a4 gene [45]. Additional studies
would be required to clarify any role of these modifica-
tions in the observed change in expression of this gene.
Histone modifications
Previous research has shown that in addition to causing
promoter DNA demethylation, selenium (in the form of
selenite) can decrease histone deacetylase activity,
increase levels of acetylated lysine 9 on histone H3
(H3-Lys 9), and (as a result of the increased acetylation)
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cer cell lines [46]. Supplementation with the methyl
group donors folate (2 mg/kg), methionine (0.4%), and
choline bitartrate (0.3%) has been shown to affect his-
tone modifications (decreasing histone H3K9me3
levels) when compared with mice fed a diet with low
folate, and lacking choline and methionine [47]. Fur-
thermore, studies of a choline and methyl-deficient
C57BL/6 mouse prostate cancer model suggest that
chromatin modifications are more susceptible to
methyl-deficient diets than DNA methylation at certain
loci [48].
The current study is the first to our knowledge that
has attempted to investigate the effects of a combination
of selenium and folate on histone modifications. We
showed adequate selenium and folate post-weaning did
not affect global histone modifications in the liver of
mice fed high-fat diets. There could be a number of rea-
sons for this. Previous studies have used diets deficient
in other methyl donors such as choline and methionine.
This suggests that folate deficiency, even in the presence
of a selenium deficiency, may not be sufficient to trigger
global histone changes in the tissues studied. In addition,
it may be that there are modifications occurring at his-
tone sites associated with specific genes, and the global
approach we have applied was not sufficiently sensitive
to evaluate such changes. Future studies including meas-
urement of gene-specific histone modifications using, for
example, chromatin immunoprecipitation (ChIP) experi-
ments would help to clarify this point.
Conclusions
The data described here show that in addition to
changes in gene and protein expression in metabolic and
oxidative pathways, altering dietary levels of selenium
and folate post-weaning can alter global DNA methyla-
tion. Because epigenetic mechanisms such as DNA
methylation may have a role in disease processes, modu-
lation of these by micronutrient supplementation may
play a role in preventing or ameliorating negative health
outcomes from inadequate nutrition. Further research is
required to establish if epigenetic mechanisms are medi-
ating the specific changes observed in gene and protein
expression, and if so which are the precise mechanisms
involved. In addition, further studies are required to es-
tablish whether there are any confounding effects due to
combining selenium and folate, or to establish whether
there is any interaction between these two compounds.
Finally, it has been suggested that a five week dietary
‘run-in’ period is required to systemically reduce folate
levels in mice [49], and data from rats suggest that at
least 4 weeks may be required to deplete selenium [50].
While liver selenium content of the HF-low-low animals
was less than that of the HF-low-suf animals in ourstudy, it was not as low as has been observed in other
studies which used a similar level of dietary selenium
but had a longer feeding period [51]. While we do not
have data on liver or colon folate levels, or colon selen-
ium levels, of the mice in our study due to insufficient
sample being available, it seems possible that these levels
would not have been significantly reduced until early
lactation due to our relatively short run-in period. Fu-
ture studies could include a minimum five week run-in
period, as well as measurement of selenium and folate
[52] levels in red blood cells, colon and liver, to confirm
that significant depletion had occurred and to more




All procedures involving animals were approved by the
Grasslands Animal Ethics Committee under the New
Zealand Animal Welfare Act 1999.
A pelleted “Western” diet [53,54] (D12079B; Research
Diets, New Brunswick, NJ 08901, USA) containing 40%,
42% and 17% kcal from fat, carbohydrate and protein,
respectively (Additional file 4: Table S3) was modified to
contain either 0.4 mg/kg folate and 0.1 mg/kg selenium
(high-fat, low selenium and folate; HF-low) or 1.8 mg/kg
folate and 0.60 mg/kg selenium (high-fat, adequate sel-
enium and folate; HF-suf). Analysis of the diets after
manufacture confirmed that these were the actual levels
of selenium and folate. These levels of folate and selen-
ium are commonly used for supplementation in mouse
and rat diets [34,55,56] and are also in accordance with
National Research Council guidelines for Laboratory An-
imals. Additional ethoxyquin was included in both diets
to prevent rancidity (Additional file 4: Table S3).
Thirty five female wild type C57BL-6 mice (Animal Re-
source Centre, Western Australia) were fed a HF-Low diet
for 7 days prior to mating with male C57BL-6 mice
(Ruakura Small Animal Facility, Hamilton, New Zealand).
An important epigenetic period is oocyte maturation,
which in the mouse is 3.5 days prior to fertilisation [57].
The experimental diet was therefore introduced prior to
the phase of oestrus during which pregnancy occurs, i.e., a
minimum of 4 days prior to mating [58]. Once pregnancy
was confirmed via the presence of a vaginal plug, males
were removed from the mating cages. The breeding dams
were maintained on the HF-low diets during mating, ges-
tation and lactation. Offspring remained with their dams
until weaning (c. 28 days of age). At weaning, female
offspring were randomly allocated to either the HF-low
diet (n = 6; HF-low/low) or switched to the HF-Suf diet
(n = 6; HF-low/suf) until 12 weeks of age. Mice were of-
fered 20 g of food pellets twice weekly and had ad libitum
access to water. Food intake (estimated by collecting and
Bermingham et al. BMC Medical Genomics 2013, 6:7 Page 13 of 18
http://www.biomedcentral.com/1755-8794/6/7weighing uneaten food) and bodyweight were determined
twice weekly. General health score was determined daily.
The mice were euthanised at 12 weeks of age via CO2
asphyxiation and cervical dislocation. Prior to tissue col-
lection, mice were fasted and re-fed to minimise vari-
ation in food intake immediately before sampling [59].
Colon tissue and liver were excised, washed in cold sa-
line and stored in tubes containing 1 mL of RNA later,
then stored at 4°C overnight. The RNA later was re-
moved and the tissues snap-frozen in liquid nitrogen
and stored at −85°C until analysis.
RNA and DNA isolation
Genomic DNA, total RNA and protein from whole
colon and liver tissue was extracted using an AllPrepW
DNA/RNA/Protein mini kit (Qiagen, Cat number
80004). DNA was quantified using a NanoDrop ND1000
(Thermo Fisher Scientific) and stored at −20°C until re-
quired for further analyses. Quality of the genomic DNA
for subsequent analyses was determined by agarose gel
electrophoresis. Total RNA was quantified using a
NanoDrop ND1000 and RNA quality was determined
using an Agilent 2100 Bioanalyser (Agilent Technolo-
gies, Palo Alto, CA, USA) to measure the RNA integrity
number (RIN). RNA was stored at −85°C until required
for microarray analysis.
Microarray hybridization and analysis
Microarray hybridization has been described in detail else-
where [60]. Briefly, a reference design was used for micro-
array hybridization: intestinal and liver RNA extracts from
all mice were pooled in an equimolar proportion and used
as the reference sample. Cy3-labelled sample cRNA
(0.75 μg) and Cy5-labelled reference cRNA (0.75 μg) was
prepared using an in situ hybridization kit-plus (Agilent
Technologies Inc., Palo Alto, California, USA) and
hybridised to Agilent Technologies Mouse G4122F – 4x44k
60mer oligonucleotide arrays, as previously described [61].
Slides were scanned using an Agilent scanner after an auto-
matic gain and calibration prior to each scan. Spot identifi-
cation and quantification were performed using Agilent
Feature Extraction software version 9.5. Microarray fluores-
cence signals were normalized using a global loess algorithm
in R2.14.1 with the Linear Models for Microarray Data
(limma) package [62]. Differentially expressed genes were
determined using an Empirical Bayes modified t-statistic
from a linear model of microarray analysis. Genes with a
greater than 1.5 fold change and a P value less than 0.01
were considered to be differentially expressed. Significantly
over-represented Gene Ontology biological processes among
differentially expressed genes were determined using the
GOStats package in R 2.14.1 [63]. The data discussed in this
publication have been deposited in NCBI’s Gene Expression
Omnibus [64] and are accessible through GEO Seriesaccession number GSE43038 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE43038).
Protein expression profiles and analysis
Sample preparation, 2D-gel electrophoresis, LC-MS pep-
tide analysis and database searching were all performed
as previously described [65]. Briefly, duplicate technical
replicates of pooled aliquots of protein (50 μg per treat-
ment, representing protein pooled from the 6 mice per
treatment group used for microarray analysis) were la-
beled with 200 pmol CyDyes (GE Healthcare) as per
manufacturer’s instructions. In all cases, HF-low-low
mice were labeled with Cy2 and HF-low-suf samples
were labeled with Cy5. Each control and test pair was
mixed to give 100 μg of protein and run on the same
first dimension strip, which (along with equilibration, sec-
ond dimension, scanning, and staining) was performed as
previously described [65]. Spot detection, warping, and
statistical analysis were performed using Delta2D 4.2 soft-
ware from Decodon (Greifswald, Germany). For accurate
spot detection, settings were chosen according to manufac-
turer’s instructions (Decodon). Gel images were first warped
using a combination of the ‘exact’ warping setting with add-
itional manual vector adjustment. A fusion gel image was
created using the ‘union’ mode (a weighted mean across the
gel series). Spot detection on the fusion gel was performed
automatically by the software, and manual editing was used
to create the end product, spot boundaries from which were
then transferred to all gels in the series. Normalised values
following background subtraction were calculated by the
software and a ratio of normalised volumes to that of the
parent gel was used for quantitative analysis of protein ex-
pression level.
Differentially expressed proteins were only flagged as
significant where the fold abundance was greater than 2,
and the t-test value was greater than 95%. Digestion of
the differentially expressed proteins for subsequent iden-
tification was carried out as previously described [65].
Tryptic peptides were separated and analyzed using an
Ettan multidimensional liquid chromatography system
(GE Healthcare) coupled to an LTQ linear ion trap mass
spectrometer with a nano-spray ionization interface
(ThermoQuest, Finnigan, San Jose, CA, USA) [66]. MS/
MS data were analyzed using TurboSEQUEST protein
identification software [67,68] and spectra were searched
against the National Center for Biotechnology Informa-
tion (NCBI) Mus musculus database. All matched pep-
tides were confirmed by visual examination of the
spectra.
Functional analysis of proteins
Functional classification of proteins was based on
GeneOntology using the Mouse Genome Informatics
(MGI) database (http://www.informatics.jax.org/), the
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encyclopedia (http://www.genome.jp/kegg/genes.html),
and Ingenuity Pathways Analysis (IPA) (Ingenuity Systems,
http://www.ingenuity.com/), as previously described [66].
Global DNA methylation and histone modifications
Genomic DNA extracted from the colon and liver tis-
sues was used to determine global DNA methylation
using high performance liquid chromatography (HPLC)
as described previously [69]. Briefly, 50 μg genomic
DNA was treated with RNase enzymes to remove con-
taminating RNA, then enzymatically hydrolysed to
mononucleotides. The samples were run on the HPLC
and detected at an absorbance of 280 nm. The relative
amounts of methylated and unmethylated cytosine were
determined using the area under the peak for each
nucleotide.
In order to assess the effects of adequate levels of sel-
enium and folate supplementation on histone modifica-
tions profiles in the liver previously reported methods
[70,71] were modified in order to significantly increase
the concentration of nuclear proteins by combining both
the nuclear pellet and supernatant. 50 mg of frozen tis-
sue was homogenised in 0.5 ml of ice-cold low salt ex-
traction buffer (10 mM HEPES (pH 7.9), 10 mM KCl,
1.5 mM MgCl2, 1 mM DTT, 5 mM sodium butyrate,
20 mM NaF and a complete protease inhibitor cocktail
(Roche)) and incubated on ice for 15 min. Igepal was
added to a final concentration of 0.1% and incubated for
a further 20 min on ice. Pellets remaining after centrifu-
gation (17 500 × g, 5 min, 4°C) were washed four times
with low salt extraction buffer then resuspended in
150 μl of ice-cold high salt extraction buffer (920 mM
HEPES (pH 7.9), 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 5 mM sodium butyrate, 1 mM DTT, 20 mM NaF
and a complete protease inhibitor cocktail). Samples
were incubated on ice for 30 min using a rocking plat-
form and centrifuged at 17 500 × g, 4°C for 15 min. The
supernatant was collected and stored on ice while the
pellet was resuspended in a minimal volume of precipi-
tation buffer (50 mM Tris–HCl (pH 7.6), 10 mM NaCl,
2 mM EDTA, 1 mM PMSF, 10 μg/ml aprotinin, 1%
Igepal, 5 mM sodium butyrate and DNAse to a final
concentration of 5 μg/mL), incubated for 30 minutes at
room temperature to degrade genomic DNA, and
centrifuged (17 500 × g, 4°C, 1 min). This supernatant
was added to the previous supernatant and stored at
−80°C for further studies. Protein concentration was de-
termined using the Thermo Scientific Pierce Coomassie
(Bradford) Protein Assay Kit according to the manufac-
turer’s instructions (Thermofisher Scientific Inc., Rock-
ford, Illinois, USA).
Western blot analysis was performed in triplicate on
nuclear protein extracts (20 μg) isolated from liver usingpolyclonal anti-acetylated histone 3 (lys9 (H3K9ac); Cell
Signaling Technology, Inc., Danvers, Massachusetts,
USA), and polyclonal anti-dimethylated histone 3 (lys9
(H3K9me2); Cell Signaling) antibodies. Equal loading of
samples was confirmed by staining with coomassie blue
(Simply Blue™ Safestain, Invitrogen, Carlsbad, California,
USA). Films were scanned and bands analysed using the
ImageJ software to determine the average peak density.
Statistical analysis of results was performed using a two
tailed Student’s t-Test. Correlation analysis between values
for the two types of histone modification was performed
using the Spearman rho correlation coefficient.
Gene specific DNA methylation
Microarray data showed consistent increased Slc22a4
mRNA abundance due to selenium and folate supplemen-
tation, with 8 separate probes for this gene on the array
showing a >2-fold down-regulation (range −2.10 to −2.39)
therefore this gene was chosen to investigate the effects of
post-weaning selenium and folate supplement on gene-
specific DNA methylation in mice fed high-fat diets.
Genomic DNA was purified from liver tissue using the
AllPrepW DNA/RNA/Protein mini kit as described above.
Quantitative analysis of DNA methylation of Slc22a4 was
performed using the Sequenom MassARRAY Compact
System (http://www.sequenom.com/). Briefly, this in-
volves the gene-specific amplification of bisulfite-treated
DNA, followed by in vitro transcription and analysis by
matrix-assisted laser desorption ionization time-of-flight
(MALDI-TOF) mass spectrometry [72]. 1 μg of DNA was
bisulfite-converted using an EZ DNA Methylation kit
(Zymo Research, Irvine, California, USA). Sequenom
EpiDesigner software was used to design PCR primers
specific for bisulfite-converted DNA. Each reverse primer
contained a T7-promoter tag for in vitro transcription
(50-cagtaatacgactcactatagggagaaggct-30), and the forward
primer was tagged with a 10mer to balance Tm
(50-aggaagagag-30). Two sets of primer pairs were designed,
generating two amplicons: one of 374 bases (referred to as
“pp_27”) encompassing the transcription start site of the
Slc22a4 gene and including part of a CpG island within that
region, and a second of 323 bases (“pp_46”) 976 base pairs
upstream of the transcription start site and immediately up-
stream of a CpG island in that region. Details of the primer
pairs are shown in Table 4, and their positions relative to
the Slc22a4 transcription start site are shown in Figure 4.
Bisulfite-treated DNA was PCR amplified (Qiagen
HotStar Taq Polymerase; Bio-Strategy Ltd, Auckland, NZ)
and treated with Shrimp Alkaline Phosphatase (Sequenom,
Queensland, Australia), heat inactivated, and a simultan-
eous in vitro transcription/uracil-cleavage reaction was car-
ried out. Transcription cleavage products were desalted
and spotted on a 384-pad SpectroCHIP (Sequenom) using
a MassARRAY nanodispenser (Samsung). Mass spectra
Table 4 Primers for sequenom analysis of CpG methylation of the Slc2a4 promoter region
Amplicon ID mus_Slc2a4_pp27 mus_Slc2a4_pp46
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(Bruker-Sequenom) and peak detection, signal-to-noise
calculations and quantitative CpG site methylation analysis
were performed using proprietary EpiTyper software v1.0.5
(Sequenom). For fragments containing a single CpG site,
DNA methylation state was calculated by the ratio of
methylated to un-methylated fragments. For cleavage prod-
ucts containing multiple CpG sites the average methylation
status of the fragment is reported.
Analysis of liver selenium
Liver selenium content was measured using HNO3/
HClO4 digestion, followed by hydride generation atomic
absorption spectroscopy. Analysis was performed byEurofins New Zealand (Ruakura Research Centre,
Hamilton, New Zealand; http://www.eurofins.co.nz/).
Statistical analysis
Food intake and bodyweight data were analysed using
the Residual Maximum Likelihood (REML) method with
a Repeated Measurements Model fitted (GenStat Release
12.2). Global DNA methylation data and liver selenium
data were compared using analysis of variance (ANOVA;
GenStat Version 9). Gene-specific methylation data was
analysed using REML (GenStat Release 14.1). Additional
statistical analyses were performed as described for the
specific method in question. All data relate to n = 6 mice
per treatment. This is because data from our previous
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lysis of RNA obtained from either 5 or 6 individual mice
per treatment is sufficient to robustly identify differen-
tially expressed transcripts. We therefore used RNA
from 6 animals in each treatment group for microarray
analysis in the current study, and used data derived from
these mice for all other analyses.
Additional files
Additional file 1: Table S1. Differentially expressed genes in the colon
of mice supplemented with adequate levels of selenium and folate post-
weaning (n = 6 per treatment). A positive fold change indicates that
supplementation increased the expression of the gene.
Additional file 2: Table S2. Differentially expressed genes in the liver
of mice supplemented with adequate levels of selenium and folate post-
weaning (n = 6 per treatment). A positive fold change indicates that
supplementation increased the expression of the gene.
Additional file 3: Figure S1. 2D-DIGE gel representing differentially
expressed proteins identified in the liver tissue of female C57 mouse fed
a high-fat diet supplemented with adequate selenium and folate
(HF-low-suf) born to mothers fed a high-fat diet without
supplementation, compared to female offspring maintained on the un-
supplemented diet (HF-low-low). Protein annotations are shown in
Figure 1 of the main text. The approximate pI and molecular weight
(MW) in kDa are given on the x and y axes, respectively.
Additional file 4: Table S3. Composition of diets used to determine
the effects of post-weaning supplementation with adequate levels of
selenium and folate in mice fed high-fat diets.
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